Arch Pharmachem Ltd, a active public limited company, was established on 05 December 2000 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the pharma sector, it holds CIN: U24231MH2000PLC129882. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.16 Cr.
Formerly known as Starazzo Pharmachem P Ltd, Arch Pharmachem P Ltd. It upholds a compliant status. Its leadership includes Ajit Annu Kamath (Director), Rajendra Padmanabhan Kaimal (Director), Chetan Ajitkumar Shah (Director). Past directors included Manoor Sayed Husain Sayed, Manoj Tejraj Jain, Sajid Ali Asad Ali Khan. It holds ₹3.90 Cr open charges and ₹55.00 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Unit No. 301,302 And 303, H Wing 3Rd Floor, Tex Centre ,, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Mumbai, Maharashtra, 400072.
U24231MH2000PLC129882
129882
05 December 2000
₹1.25 Cr
₹1.16 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Arch Pharmachem Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajit Annu Kamath | Director | 29 Jul 2003 | Current |
| Rajendra Padmanabhan Kaimal | Director | 29 Jul 2003 | Current |
| Chetan Ajitkumar Shah | Director | 27 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Mar 2019 | Past |
| Pramod Abcsdd | Director | 15 Jul 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arch Pharmachem Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 17180% increase. The company also saw a substantial improvement in profitability, with a 25.11% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Arch Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹39,000,000.00
₹550,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2003 | Sahakari Bank Ltd. | ₹5.00 M | Open |
| 02 Jan 2003 | Sahakari Bank Ltd. | ₹8.50 M | Open |
| 05 Oct 2002 | Sahakari Bank Ltd. | ₹2.55 Cr | Open |
| 18 Nov 2008 | Standard Chartered Investments And Loans India Limited | ₹55.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Arch Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Arch Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Arch Pharmachem Ltd last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Arch Pharmachem Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Progress on Chetan Ajitkumar Shah was appointed as a Director was appointed as a Director on 27 Oct 2017 & has been associated with this company since 8 years 1 month . was documented.
Progress on A charge registered on 18 Nov 2008 via Charge ID 10135594 with Standard Chartered Investments And Loans India Limited was fully satisfied on 18 Jun 2010. was documented.
The activity A charge with Standard Chartered Investments And Loans India Limited amounted to Rs. 55.00 Cr with Charge ID 10135594 was registered on 18 Nov 2008. was completed.
Ajit Annu Kamath was appointed as a Director was appointed as a Director on 29 Jul 2003 & has been associated with this company since 22 years 4 months . was recorded as a recent event.
The CIN of Arch Pharmachem Ltd is U24231MH2000PLC129882.
Arch Pharmachem Ltd is headquartered at Unit No. 301,302 And 303, H Wing 3Rd Floor, Tex Centre ,, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Mumbai, Maharashtra, 400072.
Arch Pharmachem Ltd was incorporated on 05 December 2000.
The current directors of Arch Pharmachem Ltd are
The primary industry of Arch Pharmachem Ltd is Pharma.
Arch Pharmachem Ltd is unlisted.
The authorized capital of Arch Pharmachem Ltd is ₹1.25 Cr, and the paid-up capital is ₹1.16 Cr.
The compliance status of Arch Pharmachem Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX